Coronavirus Research

Researchers from the Perelman School of Medicine and Children’s Hospital of Philadelphia found that COVID vaccinations provide more robust protection for pregnant mothers than COVID infection, with a quote from CHOP’s Dustin Flannery.

A profile examines the life and career of the Perelman School of Medicine’s Paul Offit, from his advocacy for vaccines to his criticism of FDA attitudes toward the new bivalent boosters.

John Wherry of the Perelman School of Medicine says that bivalent vaccines are not providing perfect protection from omicron variants.

On an episode of “All Things Considered,” Paul Offit of the Perelman School of Medicine says that there’s no evidence yet that the bivalent vaccine is any better than the original COVID vaccines.

Katalin Karikó of the Perelman School of Medicine is lauded for her work with Perelman’s Drew Weissman pioneering the use of synthetic messenger RNA to fight diseases, which served as the basis for two widely used COVID-19 vaccines.

Paul Offit of the Perelman School of Medicine says that uncertain benefits for children and lack of historical data on bivalent vaccines might not justify pediatric authorizations for omicron boosters.

In Drew Weissman’s lab at the Perelman School of Medicine, researchers like Mohamad-Gabriel Alameh, Benjamin Davis, and Garima Dwivedi are developing pan-coronavirus vaccines to guard against future variants.

Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for their key 2005 advances with synthetic mRNA.